Patten & Patten’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.66M Sell
23,369
-25
-0.1% -$3.75K 0.19% 99
2026
Q1
$3.57M Sell
23,394
-300
-1% -$46K 0.22% 95
2025
Q4
$3.27M Sell
23,694
-233
-1% -$30.5K 0.19% 97
2025
Q3
$3.07M Sell
23,927
-458
-2% -$55.9K 0.18% 97
2025
Q2
$2.95M Sell
24,385
-2,852
-10% -$321K 0.19% 97
2025
Q1
$3.04M Sell
27,237
-2,823
-9% -$301K 0.2% 91
2024
Q4
$2.93M Sell
30,060
-2,625
-8% -$280K 0.19% 93
2024
Q3
$3.76M Sell
32,685
-1,895
-5% -$215K 0.25% 77
2024
Q2
$3.68M Sell
34,580
-920
-3% -$92.3K 0.26% 75
2024
Q1
$3.43M Sell
35,500
-100
-0.3% -$10.3K 0.24% 78
2023
Q4
$3.59M Sell
35,600
-1,860
-5% -$180K 0.3% 71
2023
Q3
$3.82M Buy
37,460
+560
+2% +$56.8K 0.34% 68
2023
Q2
$3.72M Buy
36,900
+457
+1% +$45.7K 0.31% 74
2023
Q1
$3.35M Sell
36,443
-10,139
-22% -$885K 0.29% 77
2022
Q4
$4.23M Sell
46,582
-3,356
-7% -$283K 0.38% 69
2022
Q3
$3.8M Sell
49,938
-1,647
-3% -$137K 0.36% 73
2022
Q2
$4.36M Sell
51,585
-2,738
-5% -$240K 0.38% 72
2022
Q1
$4.77M Sell
54,323
-137
-0.3% -$11.9K 0.35% 75
2021
Q4
$4.76M Sell
54,460
-2,518
-4% -$209K 0.33% 75
2021
Q3
$4.66M Sell
56,978
-2,110
-4% -$190K 0.35% 73
2021
Q2
$5.39M Sell
59,088
-2,909
-5% -$259K 0.41% 68
2021
Q1
$5.3M Sell
61,997
-1,772
-3% -$159K 0.43% 65
2020
Q4
$6.02M Sell
63,769
-2,003
-3% -$175K 0.52% 54
2020
Q3
$5.72M Sell
65,772
-171
-0.3% -$14.8K 0.57% 48
2020
Q2
$5.76M Sell
65,943
-523
-0.8% -$45.1K 0.63% 45
2020
Q1
$5.48M Sell
66,466
-3,109
-4% -$277K 0.72% 42
2019
Q4
$6.59M Sell
69,575
-76
-0.1% -$6.82K 0.66% 50
2019
Q3
$6.05M Sell
69,651
-2,438
-3% -$219K 0.66% 51
2019
Q2
$6.58M Sell
72,089
-6,770
-9% -$573K 0.71% 48
2019
Q1
$6.79M Buy
78,859
+2,859
+4% +$230K 0.75% 48
2018
Q4
$5.84M Buy
76,000
+3,694
+5% +$288K 0.72% 51
2018
Q3
$5.58M Sell
72,306
-3,133
-4% -$232K 0.55% 56
2018
Q2
$5.11M Sell
75,439
-7,835
-9% -$541K 0.52% 54
2018
Q1
$6.03M Buy
83,274
+113
+0.1% +$8.6K 0.62% 50
2017
Q4
$6.26M Sell
83,161
-4,880
-6% -$368K 0.63% 52
2017
Q3
$6.77M Sell
88,041
-6,544
-7% -$494K 0.71% 46
2017
Q2
$7.07M Sell
94,585
-108
-0.1% -$7.65K 0.78% 45
2017
Q1
$6.3M Sell
94,693
-6,125
-6% -$408K 0.73% 48
2016
Q4
$6.58M Sell
100,818
-5,098
-5% -$331K 0.81% 39
2016
Q3
$7.49M Sell
105,916
-49
-0% -$3.57K 0.97% 32
2016
Q2
$7.83M Sell
105,965
-431
-0.4% -$29.8K 1.08% 28
2016
Q1
$6.91M Sell
106,396
-1,104
-1% -$75.1K 0.99% 31
2015
Q4
$8.29M Buy
107,500
+3,789
+4% +$301K 1.15% 27
2015
Q3
$8.54M Buy
103,711
+1,542
+2% +$137K 1.3% 25
2015
Q2
$9M Sell
102,169
-870
-0.8% -$79.8K 1.31% 22
2015
Q1
$9.11M Sell
103,039
-587
-0.6% -$52.1K 1.31% 20
2014
Q4
$8.6M Buy
103,626
+998
+1% +$82.7K 1.3% 23
2014
Q3
$8.66M Sell
102,628
-566
-0.5% -$45.8K 1.38% 22
2014
Q2
$8.37M Sell
103,194
-25,579
-20% -$2.01M 1.36% 22
2014
Q1
$9.81M Sell
128,773
-1,004
-0.8% -$73.2K 1.33% 18
2013
Q4
$9.35M Sell
129,777
-2,489
-2% -$173K 1.3% 23
2013
Q3
$9.09M Sell
132,266
-2,908
-2% -$192K 1.41% 21
2013
Q2
$8.56M Buy
+135,174
New +$8.79M 1.4% 23

Other funds holding NVS

Patten & Patten's NVS Position: Q2 2026 in Review

Patten & Patten reduced its Novartis (NVS) stake by 0.11% in Q2 2026, selling an estimated $3.75K and leaving 23,369 shares worth $3.66M. The position accounts for 0.19% of the portfolio, ranked #99.

Patten & Patten first reported a position in NVS in Q2 2013 and has held it in 53 quarters since. The position peaked at $9.81M in Q1 2014. 1,094 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Patten & Patten held 23,369 shares of Novartis worth $3.66M as of Q2 2026.
  • Patten & Patten sold 25 Novartis shares in Q2 2026, an estimated $3.75K.
  • Novartis made up 0.19% of Patten & Patten's portfolio in Q2 2026, its #99 holding.
  • Patten & Patten first reported a position in Novartis in Q2 2013 and has held it in 53 quarters since.
  • Patten & Patten's Novartis position peaked at $9.81M in Q1 2014.
  • 1,094 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Patten & Patten's 13F filing for Q2 2026, filed 5 Aug 2026.